The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement
Sponsored by University of California, San Francisco
About this trial
Last updated 3 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- adult (male and female) subjects aged 18 to 75,
- English speaking,
- are scheduled for primary total knee arthroplasty with planned spinal anesthesia with saphenous peripheral nerve block at the adductor canal.
Exclusion Criteria
- general anesthesia,
- hepatic & renal failure,
- history of diabetic peripheral neuropathic pain,
- chronic opioid use,
- concurrent use of antidepressants, triptans, and/or linezolid,
- allergy to the study medications,
- prior knee surgery,
- BMI > 40,
- bleeding disorders,
- history of recent falls,
- concurrent benzodiazepine use.